Union MoS for Health and Family Welfare Smt. Anupriya Patel launches 7th National Formulary of India 2026, announces Biovigilance Programme to widen India’s patient-safety net

The Union Minister of State for Health and Family Welfare launched the 7th Edition of the National Formulary of India (NFI) 2026, the Guidance Document for Hospitals in India for Safety Monitoring and Reporting of Medical Device-Related Adverse Events, and the ADR-PvPI 2.0 Mobile App during the 6th National Pharmacovigilance Week. Additionally, the Government approved the Biovigilance Programme of India, led by the Indian Pharmacopoeia Commission (IPC), to monitor adverse events associated with organ and tissue transplantation. India's contributions to the WHO patient safety database rose from the 123rd position during 2009–2014 to 8th globally. The expanded initiatives integrate pharmacovigilance, materiovigilance, and biovigilance to strengthen patient safety across medicines, medical devices, and transplant procedures.